Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.15 mg (a) 2 prefilled auto injectors + 1 tra...

FDA Drug Recall #D-0873-2016 — Class I — October 28, 2015

Recall Summary

Recall Number D-0873-2016
Classification Class I — Serious risk
Date Initiated October 28, 2015
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Sanofi-Aventis U.S. LLC
Location Bridgewater, NJ
Product Type Drugs
Quantity 159,000 prefilled injectors

Product Description

Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.15 mg (a) 2 prefilled auto injectors + 1 trainer (NDC 0024-5831-02) and (b) 1 prefilled auto injector + 1 trainer (NDC 0024-5831-00), Rx Only, Manufactured for Sanofi-Aventis US, LLC Bridgewater, NJ 08807 A Sanofi Company

Reason for Recall

Defective Delivery System; potential to have inaccurate dosage delivery

Distribution Pattern

Nationwide

Lot / Code Information

a) 2144144, exp 10/2015; 2469674, exp 04/2016; 2506492, 2546978, 2546979, exp 05/2016; 2654817, 2654818, exp 06/2016; 2692143, 2692144, exp 07/2016; 2719838, exp 08/2016; 2824845, 2891021, 2857530, exp 09/2016; 2883631, 2883632, exp 10/2016; 2883633, 2945429, 3028243, exp 11/2016; 3037230, 2966680, 2974276, 2974280, exp 12/2016; and b) 2525474, exp 05/2016

Other Recalls from Sanofi-Aventis U.S. LLC

Recall # Classification Product Date
D-0575-2023 Class II Admelog, insulin lispro injection, 100 units/mL... Apr 11, 2023
D-1507-2020 Class II Elitek (rasburicase) for injection, 7.5 mg vial... Aug 10, 2020
D-0534-2020 Class II Cool Mint Tablets Maximum Strength Zantac 150 m... Oct 22, 2019
D-0540-2020 Class II Regular Strength Zantac 75 mg, Distributed by: ... Oct 22, 2019
D-0542-2020 Class II Regular Strength Zantac 75 mg, Distributed by: ... Oct 22, 2019

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.